LT2552434T - Peptidai ir jų naudojimas - Google Patents

Peptidai ir jų naudojimas

Info

Publication number
LT2552434T
LT2552434T LTEP11730384.2T LT11730384T LT2552434T LT 2552434 T LT2552434 T LT 2552434T LT 11730384 T LT11730384 T LT 11730384T LT 2552434 T LT2552434 T LT 2552434T
Authority
LT
Lithuania
Prior art keywords
peptides
Prior art date
Application number
LTEP11730384.2T
Other languages
English (en)
Lithuanian (lt)
Inventor
Deborah O`NEIL
Derry Mercer
Cedric Charrier
Original Assignee
Novabiotics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2010/000631 external-priority patent/WO2010112848A2/en
Application filed by Novabiotics Limited filed Critical Novabiotics Limited
Publication of LT2552434T publication Critical patent/LT2552434T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
LTEP11730384.2T 2010-03-31 2011-03-30 Peptidai ir jų naudojimas LT2552434T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/GB2010/000631 WO2010112848A2 (en) 2009-03-31 2010-03-31 Inhibition of biofilm organisms
US39008110P 2010-10-05 2010-10-05
GBGB1016733.6A GB201016733D0 (en) 2010-10-05 2010-10-05 Compounds and their use
PCT/GB2011/000480 WO2011121289A2 (en) 2010-03-31 2011-03-30 Compounds and their use

Publications (1)

Publication Number Publication Date
LT2552434T true LT2552434T (lt) 2019-07-25

Family

ID=43243521

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11730384.2T LT2552434T (lt) 2010-03-31 2011-03-30 Peptidai ir jų naudojimas

Country Status (29)

Country Link
US (1) US8901071B2 (OSRAM)
EP (3) EP3479824A3 (OSRAM)
JP (1) JP5969457B2 (OSRAM)
KR (1) KR101922409B1 (OSRAM)
CN (1) CN102906105B (OSRAM)
AU (3) AU2011234252B2 (OSRAM)
BR (1) BR112012024676B1 (OSRAM)
CA (1) CA2797437C (OSRAM)
CY (1) CY1121658T1 (OSRAM)
DK (1) DK2552434T3 (OSRAM)
ES (1) ES2729313T3 (OSRAM)
GB (1) GB201016733D0 (OSRAM)
HR (1) HRP20190982T1 (OSRAM)
HU (1) HUE044549T2 (OSRAM)
IL (1) IL222027A (OSRAM)
LT (1) LT2552434T (OSRAM)
MX (1) MX2012011369A (OSRAM)
NZ (2) NZ603200A (OSRAM)
PL (1) PL2552434T3 (OSRAM)
PT (1) PT2552434T (OSRAM)
RS (1) RS58980B1 (OSRAM)
RU (1) RU2590706C2 (OSRAM)
SG (1) SG184138A1 (OSRAM)
SI (1) SI2552434T1 (OSRAM)
SM (1) SMT201900365T1 (OSRAM)
TR (1) TR201908150T4 (OSRAM)
UA (1) UA118167C2 (OSRAM)
WO (1) WO2011121289A2 (OSRAM)
ZA (1) ZA201208173B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150231199A1 (en) * 2012-09-07 2015-08-20 Agency For Science, Technology And Research Peptides and their uses
US20150119345A1 (en) * 2013-10-29 2015-04-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of gastrointestinal infections
GB2522412A (en) * 2014-01-22 2015-07-29 Agency Science Tech & Res Antimicrobial peptidomimetics
DE102014101663A1 (de) * 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
GB2524777A (en) * 2014-04-02 2015-10-07 Microarray Ltd Dressing comprising electrodes
US9370476B2 (en) * 2014-09-29 2016-06-21 The Research Foundation For The State University Of New York Compositions and methods for altering human cutaneous microbiome to increase growth of Staphylococcus epidermidis and reduce Staphylococcus aureus proliferation
KR101781679B1 (ko) * 2014-11-21 2017-09-26 한양대학교 산학협력단 수 처리 물질 및 그 제조 방법
US11103547B2 (en) 2016-02-04 2021-08-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
WO2018089648A2 (en) 2016-11-09 2018-05-17 Ohio State Innovation Foundation Di-sulfide containing cell penetrating peptides and methods of making and using thereof
US11352394B2 (en) 2016-11-22 2022-06-07 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
CN110582507A (zh) * 2017-03-03 2019-12-17 肽逻辑公司 工程化抗微生物两亲性肽及使用方法
WO2019023617A1 (en) * 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
WO2019090015A1 (en) * 2017-11-03 2019-05-09 Yale University Peptidic materials that traffic efficiently to the cell cytosol and nucleus
EP3746105A4 (en) 2018-01-29 2022-05-18 Ohio State Innovation Foundation CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
CN110227144A (zh) * 2019-06-12 2019-09-13 华懿思科(成都)生物科技有限公司 一种消除妇科炎症致病菌及hpv病毒的抗菌肽靶向制剂及其制备方法
WO2021156877A1 (en) * 2020-02-09 2021-08-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Antimicrobial matrix and uses thereof for eliminating microorganisms
CN111533781B (zh) * 2020-03-30 2022-02-08 东北农业大学 非特异受体结合型真菌靶向抗菌肽及其制备方法和应用
EP4192847A1 (en) * 2020-08-10 2023-06-14 Università Cattolica del Sacro Cuore New antimicrobial peptides
CN112586785B (zh) * 2020-12-03 2022-02-08 青岛大学附属医院 一种驴鞭食用胶原蛋白肽-明胶复合胶囊壁材制备方法
RU2771493C1 (ru) * 2021-04-15 2022-05-05 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Пептид, обладающий антибактериальной активностью в отношении микроорганизмов с множественной лекарственной устойчивостью
CA3221235A1 (en) * 2021-06-11 2022-12-15 Ali Ladram Short antimicrobial peptides
CN116606347B (zh) * 2023-04-28 2024-03-29 东北农业大学 一种抗菌肽frrffp及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3561444A (en) 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US3703173A (en) 1970-12-31 1972-11-21 Ted A Dixon Nebulizer and tent assembly
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
US4635627A (en) 1984-09-13 1987-01-13 Riker Laboratories, Inc. Apparatus and method
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
EP0752885B1 (en) 1992-09-25 2003-07-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB2408263A (en) * 2003-11-14 2005-05-25 Pacgen Biopharmaceuticals Inc Antimicrobial peptides with reduced hemolysis and methods of their use.
PT1778720E (pt) 2004-08-18 2010-11-29 Novabiotics Ltd Péptidos antimicrobianos compreendendo um motivo com arginina e/ou lisina
CA2587449A1 (en) * 2004-11-12 2006-05-18 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
US20070093894A1 (en) * 2005-10-25 2007-04-26 Baylor College Of Medicine Incorporation of antimicrobial combinations onto devices to reduce infection
CN100467481C (zh) * 2006-04-18 2009-03-11 河北师范大学 棕点湍蛙抗菌多肽及其在制药中的应用
CN101070341A (zh) * 2006-05-08 2007-11-14 徐永强 无致突变作用的抗菌多肽
EP2061886B1 (en) * 2006-08-21 2014-05-07 The University Of British Columbia Small cationic immunomodulatory peptides
GB0702021D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
CN101168564B (zh) * 2007-10-22 2012-03-21 中国科学院昆明动物研究所 人源性抗菌肽及其衍生物的用途
EP2168590A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms

Also Published As

Publication number Publication date
CN102906105B (zh) 2017-05-10
PL2552434T3 (pl) 2019-09-30
KR101922409B1 (ko) 2018-11-27
CA2797437C (en) 2017-11-07
EP3578193A3 (en) 2020-05-20
SI2552434T1 (sl) 2019-08-30
EP3479824A2 (en) 2019-05-08
EP3578193B1 (en) 2023-09-06
GB201016733D0 (en) 2010-11-17
US20130102524A1 (en) 2013-04-25
EP3578193A2 (en) 2019-12-11
HRP20190982T1 (hr) 2019-10-18
EP2552434B1 (en) 2019-05-08
AU2018202201A1 (en) 2018-04-26
RU2590706C2 (ru) 2016-07-10
WO2011121289A2 (en) 2011-10-06
UA118167C2 (uk) 2018-12-10
NZ603200A (en) 2014-02-28
BR112012024676B1 (pt) 2022-05-03
HUE044549T2 (hu) 2019-11-28
ES2729313T3 (es) 2019-10-31
BR112012024676A2 (pt) 2016-06-07
KR20130043625A (ko) 2013-04-30
CA2797437A1 (en) 2011-10-06
RS58980B1 (sr) 2019-08-30
US8901071B2 (en) 2014-12-02
SMT201900365T1 (it) 2019-07-11
JP2013523703A (ja) 2013-06-17
ZA201208173B (en) 2013-07-31
MX2012011369A (es) 2012-11-30
NZ618571A (en) 2015-02-27
AU2011234252A1 (en) 2012-11-22
RU2012145756A (ru) 2014-05-10
SG184138A1 (en) 2012-10-30
DK2552434T3 (da) 2019-06-11
AU2016208308A1 (en) 2016-08-11
AU2011234252B2 (en) 2016-05-12
EP2552434B9 (en) 2019-09-11
EP3479824A3 (en) 2019-08-14
PT2552434T (pt) 2019-06-12
EP2552434A2 (en) 2013-02-06
AU2018202201B2 (en) 2019-12-05
JP5969457B2 (ja) 2016-08-17
WO2011121289A3 (en) 2012-03-15
CN102906105A (zh) 2013-01-30
TR201908150T4 (tr) 2019-06-21
CY1121658T1 (el) 2020-07-31
EP3578193C0 (en) 2023-09-06
IL222027A (en) 2016-11-30
AU2016208308B2 (en) 2018-01-18

Similar Documents

Publication Publication Date Title
LT2552434T (lt) Peptidai ir jų naudojimas
LT2605789T (lt) Modifikuoti relaksino polipeptidai ir jų panaudojimas
LT2794654T (lt) Anti-phf-tau antikūnai ir jų panaudojimas
LT3725330T (lt) Stabilūs polipeptidų preparatai ir jų naudojimas
LT2726092T (lt) Sulieti serpino polipeptidai ir jų panaudojimo būdai
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
LT3495392T (lt) Anti-cgrp kompozicijos ir jų panaudojimas
IL222961B (en) DNA binding proteins and their uses
BR112013013308A2 (pt) inalador e unidade articulada
LT3470086T (lt) Pirolobenzodiazepinai ir jų konjugatai
DK2536830T3 (da) Polypeptider
LT2593463T (lt) Rifaksimino kompozicijos ir jų panaudojimas
IL225897A0 (en) Cxcr2 binding polypeptides
LT2523678T (lt) Wnt antagonistai ir gydymo būdai
FR2962645B1 (fr) Prothese marquee
DK2571624T3 (da) Multifysisk brændstofforstøver og fremgangsmåder
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
ME02224B (me) Antikancerski fuzioni protein
EP2593595A4 (en) NOVEL PEPTIDES AND USES THEREOF
PL2627668T3 (pl) Peptydy i ich zastosowanie
FR2964937B1 (fr) Triporteur et direction de triporteur
IL226461A0 (en) Quantitation of lactoferrin in infant formulas by lectrophoresis using ir fluorescence imaging
BR112013009679A2 (pt) peptídeo
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
EP2660249A4 (en) PEPTIDE DERIVATIVE AND ITS USE